FDA Announces New Warnings for Class of Diabetes Drugs

WASHINGTON, D.C. - The FDA announced on Aug. 14 that manufacturers of a class of drugs used to treat Type 2 diabetes have agreed to strengthen warnings related to an increased risk of heart failure.

According to a statement issued by the agency, new information about the risk will be included in a boxed warning, emphasizing that the drug may cause or worsen heart failure in certain patients who take the drugs.

The new warnings follow recommendations issued in July by the FDA's Endocrine and Metabolic and Drug Safety and Risk Management advisory committees after both held hearings over …